Table 2. Clinical characteristics of the GCB and non-GCB patients.
| Variable | GCB (n=111) | non-GCB (n=209) | Total (n=320) | P- value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |||||
| Age (years; mean ± STD) | 64.66 ± 13.53 | - | 67.56 ± 12.63 | - | - | - | 0.06 | |||
| Age >60 | 76 | 68.5 | 164 | 78.5 | 240 | 75 | 0.06 | |||
| Male | 68 | 61.3 | 104 | 49.8 | 172 | 53.8 | 0.06 | |||
| B symptoms | 24 (n=110) | 21.8 | 58 (n=207) | 28 | 82 (n=317) | 25.9 | 0.28 | |||
| Extranodal | 63 (n=110) | 57.3 | 151 (n=209) | 72.3 | 214 (n=319) | 67.1 | 0.008 | |||
| BM invasion | 11 (n=106) | 10.4 | 32 (n=208) | 15.4 | 43 (n=314) | 13.7 | 0.3 | |||
| High LDH (>220 U/L) | 65 (n=110) | 59.1 | 134 (n=209) | 64.1 | 199 (n=319) | 62.4 | 0.4 | |||
| Stage III/IV | 54 (n=110) | 49.1 | 117 (n=208) | 56.2 | 171 (n=318) | 53.8 | 0.24 | |||
| IPI H-I/H | 44 (n=109) | 40.4 | 96 (n=208) | 46.2 | 140 (n=317) | 44.2 | 0.34 | |||